药物对比
Tirzepatide vs Gliquidone
Tirzepatide 与 Gliquidone 治疗 2 型糖尿病的比较：双重 GIP/GLP-1 激动剂 vs 口服磺脲类。比较 A1C 降幅、体重减轻、低血糖风险和便利性。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes weighing a newer weekly injectable dual agonist against a traditional oral sulfonylurea.
结论
Tirzepatide generally outperforms Gliquidone on glycemic control and weight but requires injection and has GI effects, while Gliquidone is oral yet raises hypoglycemia risk.
全部药物对比